Alaffia lands $55M to automate health plan claims operations
Alaffia, a healthtech company building agentic AI for health plan claims operations, has raised a $55 million Series B funding round led by Transformation Capital. The round also included continued backing from FirstMark, Tau Ventures, and Twine, bringing the company’s total funding to more than $72 million.
The financing arrives as U.S. health plans face mounting pressure to cut administrative waste and improve compliance. Industry estimates cited by the company suggest insurers and health plans can lose up to $570 billion annually to administrative inefficiencies, including slow claims processing, elevated medical costs, and the growing complexity of reimbursement rules and regulations.
Turning claims processing from a cost center into a core capability
Alaffia was founded by TJ Ademiluyi and Adun Akanni with the aim of combining clinical expertise and automation to make claims decisions more accurate, consistent, and defensible. The founders say their experience in provider revenue cycle management exposed a recurring problem: claim payments are often made without full clinical context, increasing the likelihood of waste, disputes, and inaccurate reimbursements.
“We saw firsthand how often medical claim payments from payers [are] made without full clinical context, leading to waste, abuse, and inaccurate payments,” Ademiluyi said in comments included with the announcement. He added that the company was built to bring “greater accuracy, transparency, and clinical rigour” to claims decisions, with the goal of reducing waste “without increasing risk or eroding trust.”
Agentic AI across utilization, payment integrity, and appeals
The company positions its technology as an end-to-end platform that supports multiple stages of the claims lifecycle, including utilization, payment integrity, and appeals. According to the company, the system can extract clinical information from patient records with over 97% accuracy and is available either as a SaaS product or as a fully managed service.
Alaffia says its core differentiation is pairing experienced clinicians with automation that can interpret and structure clinical documentation—material that is frequently unstructured, siloed, or difficult to reconcile with billing codes and payer policies. The platform extracts key facts from medical records and supporting documents, then compares them with what providers billed to determine whether claims align with reimbursement policies and clinical guidelines.
Measured outcomes health plans can point to
In results shared by the company, Alaffia reports:
- More than 20% savings on expensive facility claims
- A fivefold return on investment
- Significantly faster review times compared with manual processes
- More than $100 million saved for health plan customers to date
Health plans have historically relied on manual clinical reviews and legacy payment integrity tools, which can be time-consuming and may introduce compliance risk. Alaffia argues that the combination of automation and clinical oversight can shorten review cycles while improving consistency and auditability—two factors that matter when payers, providers, and regulators scrutinize decisions.
Competitive landscape: beyond point solutions
The company also drew contrast with older payment integrity platforms and less transparent AI offerings. In the current market, many tools focus on a narrow slice of claims review, while newer AI systems may raise concerns about explainability and governance in clinical and reimbursement contexts.
Alaffia says it supports the full claims lifecycle and emphasizes “transparent AI with clinical oversight,” a balance it believes is required to operate within complex payer rules and deliver outcomes that stakeholders can defend. The company referenced competitors and adjacent players including Cohere Health, Olive (which has shut down), and PreFi, positioning its approach as broader in scope than point solutions.
Diversity metrics disclosed
In a notable inclusion, Ademiluyi shared workforce demographic data. According to the company, Alaffia’s team is 56% women and 44% men. Racial representation across the company is reported as 65% White, 21% Black or African American, and 12% Asian. In leadership, women represent 40%, while racial representation among leaders is 40% White, 30% Black or African American, and 30% Asian.
What the new funding will support
With the Series B capital, Alaffia plans to expand its AI capabilities and broaden the range of “agents” it deploys across different claim types. The company also said it is hiring rapidly, with roles spanning engineering, product leadership, and growth, to meet rising demand from health plans.
Looking ahead, Ademiluyi said the company intends to scale what is already working to reduce administrative waste across healthcare, while investing heavily in research and development. The roadmap includes launching new AI agents “across additional modalities” and expanding beyond payment integrity to cover more of the claims lifecycle.
Why it matters
Administrative burden remains one of the largest cost drivers in U.S. healthcare, and claims operations sit at the intersection of cost control, provider relationships, and regulatory oversight. If agentic AI systems can reliably extract clinical context, apply reimbursement policies consistently, and document decisions clearly, they may offer health plans a path to faster processing and fewer disputes—without increasing compliance risk.
The challenge, however, will be sustaining accuracy and transparency at scale across diverse data sources, provider documentation styles, and evolving payer rules. Alaffia is betting that a model combining clinician oversight with agentic AI can meet that bar.
Related
